Tower Research Capital LLC TRC Grows Stock Holdings in STERIS plc (NYSE:STE)

Tower Research Capital LLC TRC raised its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 198.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,538 shares of the medical equipment provider's stock after buying an additional 4,347 shares during the period. Tower Research Capital LLC TRC's holdings in STERIS were worth $1,344,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Norges Bank purchased a new stake in STERIS during the 4th quarter valued at about $238,836,000. Raymond James Financial Inc. purchased a new stake in shares of STERIS during the fourth quarter valued at approximately $223,987,000. Franklin Resources Inc. boosted its stake in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after purchasing an additional 529,308 shares during the period. Wellington Management Group LLP grew its holdings in shares of STERIS by 4,534.6% in the fourth quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider's stock worth $45,024,000 after purchasing an additional 214,306 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in shares of STERIS by 400.4% in the fourth quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider's stock worth $46,198,000 after buying an additional 179,829 shares during the period. 94.69% of the stock is owned by institutional investors.

STERIS Stock Down 0.3 %

STERIS stock traded down $0.66 during trading hours on Tuesday, hitting $224.60. 133,464 shares of the stock traded hands, compared to its average volume of 524,934. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The company has a market cap of $22.07 billion, a PE ratio of 47.75 and a beta of 0.87. The firm's 50-day moving average price is $222.97 and its two-hundred day moving average price is $218.84. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on STE shares. Stephens reissued an "overweight" rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Finally, Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.